Cargando…

Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial

The goal of this randomized, blinded, crossover clinical trial was to determine whether Nuedexta (dextromethorphan and quinidine) enhanced speech, swallowing, and salivation in patients with ALS. Sixty patients with amyotrophic lateral sclerosis (ALS) received either Nuedexta or placebo for 28 to 30...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Richard, Pioro, Erik, Myers, Kathleen, Sirdofsky, Michael, Goslin, Kimberly, Meekins, Gregg, Yu, Hong, Wymer, James, Cudkowicz, Merit, Macklin, Eric A., Schoenfeld, David, Pattee, Gary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509619/ https://www.ncbi.nlm.nih.gov/pubmed/28070747 http://dx.doi.org/10.1007/s13311-016-0508-5

Ejemplares similares

Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self‐report scale (Center for Neurologic Study Bulbar Function Scale)
por: Smith, R. A., et al.
Publicado: (2018)

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
por: Yunusova, Yana, et al.
Publicado: (2011)

Dextromethorphan/quinidine for the treatment of bulbar impairment in amyotrophic lateral sclerosis
por: Tabor Gray, Lauren, et al.
Publicado: (2023)

Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in patients with amyotrophic lateral sclerosis: A quantitative speech analysis
por: Green, Jordan R., et al.
Publicado: (2018)

Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect
por: Pioro, Erik P.
Publicado: (2014)

Face and content validation of the amyotrophic lateral sclerosis—Bulbar dysfunction index (ALS-BDI)
por: Yunusova, Yana, et al.
Publicado: (2023)

Military Service and Amyotrophic Lateral Sclerosis in a Population-based Cohort
por: Weisskopf, Marc G., et al.
Publicado: (2015)

Protocol for psychometric evaluation of the Amyotrophic Lateral Sclerosis - Bulbar Dysfunction Index (ALS-BDI): a prospective longitudinal study
por: Yunusova, Yana, et al.
Publicado: (2022)

Serum Ferritin and Metal Levels as Risk Factors for Amyotrophic Lateral Sclerosis
por: Qureshi, Muddasir, et al.
Publicado: (2008)

Bulbar onset amyotrophic lateral sclerosis: A case report
por: Pudasaini, Prasamsa, et al.
Publicado: (2022)

Bulbar Onset Amyotrophic Lateral Sclerosis: A Case Report
por: Rai, Kabindra, et al.
Publicado: (2023)

Misdiagnosis: Hypoglossal palsy mimicking bulbar onset amyotrophic lateral sclerosis
por: Goldstein, Eric D., et al.
Publicado: (2018)

MRI cortical feature of bulbar impairment in patients with amyotrophic lateral sclerosis
por: Donatelli, Graziella, et al.
Publicado: (2019)

Basilar invagination: A mimicker of bulbar-onset amyotrophic lateral sclerosis
por: Tan, Jason Seng Hong, et al.
Publicado: (2021)

Recurrent Lingual Abscess in an Elderly Female With Bulbar Amyotrophic Lateral Sclerosis
por: Carotenuto, Alessandro, et al.
Publicado: (2022)

Clinical Features of Isolated Bulbar Palsy of Amyotrophic Lateral Sclerosis in Chinese Population
por: Zhang, Hua-Gang, et al.
Publicado: (2017)

Two Distinct Clinical Phenotypes of Bulbar Motor Impairment in Amyotrophic Lateral Sclerosis
por: Stipancic, Kaila L., et al.
Publicado: (2021)

How to increase noninvasive ventilation effectiveness in bulbar amyotrophic lateral sclerosis patients
por: Sancho, Jesus, et al.
Publicado: (2023)

Detecting bulbar amyotrophic lateral sclerosis (ALS) using automatic acoustic analysis
por: Simmatis, Leif, et al.
Publicado: (2023)

Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosis
por: Nicholson, Katharine, et al.
Publicado: (2018)

Advanced magnetic resonance neuroimaging in bulbar and limb onset early amyotrophic lateral sclerosis
por: Vora, Maulik, et al.
Publicado: (2016)

Predicting Early Bulbar Decline in Amyotrophic Lateral Sclerosis: A Speech Subsystem Approach
por: Rong, Panying, et al.
Publicado: (2015)

Progress in respiratory management of bulbar complications of motor neuron disease/amyotrophic lateral sclerosis?
por: Simonds, Anita K
Publicado: (2017)

Agraphia in Bulbar-Onset Amyotrophic Lateral Sclerosis: Not Merely a Consequence of Dementia or Aphasia
por: Ichikawa, Hiroo, et al.
Publicado: (2008)

Squamous cell carcinoma of the base of the tongue mimicking bulbar-onset amyotrophic lateral sclerosis
por: Lin, Hsin-Pin, et al.
Publicado: (2020)

Disease duration of progression is helpful in identifying isolated bulbar palsy of amyotrophic lateral sclerosis
por: Zhang, Huagang, et al.
Publicado: (2021)

Amyotrophic Lateral Sclerosis and Novel Therapeutic Strategies
por: Morrison, Brett, et al.
Publicado: (2012)

Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
por: Goyal, Namita A., et al.
Publicado: (2020)

Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis
por: Staats, Kim A., et al.
Publicado: (2022)

The rostral to caudal gradient of clinical and electrophysiological features in sporadic amyotrophic lateral sclerosis with bulbar-onset
por: Liao, Song-Jie, et al.
Publicado: (2020)

Detecting Bulbar Involvement in Patients with Amyotrophic Lateral Sclerosis Based on Phonatory and Time-Frequency Features
por: Tena, Alberto, et al.
Publicado: (2022)

Bulbar Onset Amyotrophic Lateral Sclerosis in a COVID-19 Patient: A Case Report
por: Abu-Abaa, Mohammad, et al.
Publicado: (2023)

Bulbar involvement and cognitive features in amyotrophic lateral sclerosis: a retrospective study on 347 patients
por: Aiello, Edoardo Nicolò, et al.
Publicado: (2023)

Improving clinical trial outcomes in amyotrophic lateral sclerosis
por: Kiernan, Matthew C., et al.
Publicado: (2020)

Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes
por: Paganoni, Sabrina, et al.
Publicado: (2022)

Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis
por: Alshikho, Mohamad J., et al.
Publicado: (2016)

Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis
por: Thonhoff, Jason R., et al.
Publicado: (2022)

Antibody Response to HML‐2 May Be Protective in Amyotrophic Lateral Sclerosis
por: Garcia‐Montojo, Marta, et al.
Publicado: (2022)

Bulbar impairment score and survival of stable amyotrophic lateral sclerosis patients after noninvasive ventilation initiation
por: Sancho, Jesús, et al.
Publicado: (2018)

Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis
por: Steinbach, Robert, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cptunkl2p900c2f2afmormrnq6